|
This comment was prepared by the Hospital Pharmacists’ Group
committee, of which Richard Needle, Essex Rivers Healthcare NHS Trust
and Simon Riley (chief pharmacist, Plymouth Hospitals NHS Trust)
are respectively chairman and vice-chairman.
Please visit the HPG website (via the Society’s website)
for further information about the group and its activites. |
Recent Government initiatives, following on from the Audit Commission’s
Spoonful of sugar report1 (such as the revised performance management
framework for medicines management,2 and the Vision for Pharmacy document3)
have put hospital pharmacists at the forefront of managing medicines.
It seems as if the contribution of pharmacists in providing acute health
care services might at last be beginning to be recognised. Moreover,
this acknowledgement of the work of pharmacists is just part of the changes
that have taken place in the health care arena over the past few years.
Such changes include the dissolution of the old health authorities in
England, the devolution of health policy in Scotland and Wales to the
Scottish Executive and Welsh Assembly, the development of an increasing
number of national service frameworks and National Institute of Clinical
Excellence and Scottish Medicines Consortium guidelines, and the emergence
of the concept of clinical governance.
With all these developments in mind, it is increasingly important that
the voices of hospital pharmacists are heard, both within the Royal Pharmaceutical
Society and beyond. Otherwise, full advantage is unlikely to be taken
of the opportunites presented to us by our raised profile.
The hospital pharmacists’ group is one organisation that represents
hospital pharmacists in this way, putting across their viewpoint at available
forums. This can involve responding to specific questions from the Society,
making comments on national consultation documents or proactively raising
awareness of hospital pharmacy issues at government level.
For example, the Society asked the HPG for its views on “Agenda
for change” and HPG representatives have raised the issue of the
recruitment and retention problems experienced by hospital pharmacists
at a House of Commons Select Committee meeting on NHS staffing requirements.
The HPG has also been asked to advise the Society on its response to
the proposal to allow supplementary prescribers to prescribe unlicensed
products, issued in December 2003 by the Department of Health and the
Medicines and Healthcare products Regulatory Authority.
Aside from its role in raising the profile of hospital pharmacists with
policy makers, a key aspect of the HPG’s work is to support hospital
pharmacy practice. This can take the form of hosting workshops and symposia,
or sponsoring the development of guidance on current issues affecting
practice. As an integral part of the Society, the HPG is in a unique
position to help steer hospital pharmacy practice.In particular, the
HPG has developed guidance on the best practice involved in admitting
patients and in one stop dispensing, using patients’ own drugs
and self-administration schemes.4 It has recently published an article,
(based on the admissions guidance) on providing pharmacy services to
medicines admissions units.5 Guidance on pharmacist involvement in patient
discharge procedures is expected shortly.
The HPG has also developed an update of the Duthie report on the safe
handling of drugs, an often-quoted reference source when designing hospitals
and developing services.6 Publication is expected later this year, following
final comments from the DoH. Guidance for pharmacists involved in gene
therapy work, commissioned
by the HPG, is also expected this year.
Conferences and symposia organised by the HPG include those on adverse
drug reactions, self regulation in hospital pharmacy and the future shape
of central intravenous additive services. The HPG advises on the hospital
pharmacy content of the British Pharmaceutical Conference and (together
with the Guild of Healthcare Pharmacists and the United Kingdom Clinical
Pharmacy Association) organise the sessions.
Indeed, in both its policy-influencing and practice support roles, the
HPG works closely with the guild. Working together can only strengthen
the position for hospital pharmacy. The guild and the HPG share agendas
and meeting notes and have representation at each other’s formal
meetings. Other examples of collaboration include sharing work on pharmaceutical
standards and managing medication errors in hospitals. Initiatives to
develop the role of the consultant pharmacist are also undertaken jointly
by the two groups.
The work of the HPG is carried out by its committee, which comprises
nine elected members, a representative of the DoH and two members of
the Society’s Council. But the membership of HPG is wider than
that — all pharmacists who practise in a hospital environment are
entitled to become members of the
group, and we would encourage you to do so.
In order for the work of the HPG committee to best serve the group’s
members it is vital that pharmacists relay to committee members information
on the topics they would like to see progressed. That way, the guidance
documents produced can be driven by the needs of hospital pharmacists.
We really need you to let us know what we, the HPG committe, can do for
you.
You could also steer the group’s work by standing for election
to the committee. Nominations are now called for to represent England
[see p85]. Please take the opportunity to help influence the future face
of hospital pharmacy.
References
1. Audit Commission. A spoonful of sugar: recipes for risk reduction.
London: The Commission; 2001.
2. Department of Health. Medicines management in hospitals performance
management framework. London: The Department; 2003.
3. Department of Health. A vision for pharmacy in the new NHS.
London: The Department; 2003.
4. Hospital Pharmacists’ Group. One stop dispensing, use
of patients’ own drugs and self-adminstration schemes. Hospital
Pharmacist 2002;9:81–6 (PDF 80K)
5. Hospital Pharmacists’ Group. Providing pharmacy services
to medical admissions units. Hospital Pharmacist 2004;11:72–3
(PDF 110K)
6. NHS Executive. Guidelines for the safe and secure handling of
medicines (Duthie report). London: The Executive; 1988. |
|